Literature DB >> 15347639

Genetic relatedness of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated in south Asia.

Kaisar A Talukder1, Bijay K Khajanchi, M Aminul Islam, Dilip K Dutta, Zhahirul Islam, Ashrafus Safa, G Y Khan, Khorshed Alam, M A Hossain, Sarala Malla, S K Niyogi, Mustafizur Rahman, Haruo Watanabe, G Balakrish Nair, David A Sack.   

Abstract

OBJECTIVES: The aim of the present study was to determine the clonal relationships of ciprofloxacin-resistant Shigella dysenteriae type 1 strains isolated from south Asia, and S. dysenteriae 1 strains associated with epidemics in 1978, 1984 and 1994.
METHODS: The antimicrobial susceptibilities were examined by NCCLS methods. Molecular epidemiological characterization was performed by plasmid profiling, pulsed-field gel electrophoresis (PFGE) and mutation analysis of the quinolone resistance-determining region (QRDR) of gyrA by sequencing.
RESULTS: Plasmid patterns of the current ciprofloxacin-resistant strains from India, Nepal and Bangladesh were very similar to those of the 1978, 1984 and 1994 epidemic isolates of S. dysenteriae 1, except for the presence of a new plasmid of approximately 2.6 MDa, which was found in one recent ciprofloxacin-resistant strain isolated in Bangladesh. PFGE analysis showed that the ciprofloxacin-resistant strains isolated in Bangladesh, India and Nepal belonged to a PFGE type (type A), which was possibly related to that of the 1984 and 1994 clone of S. dysenteriae 1, but different from 1978 epidemic strains. The current ciprofloxacin-resistant strains belong to five subtypes (A3-A7), all of which were found in India, but in Bangladesh and Nepal, only A3 existed. Mutation analysis of the QRDR of gyrA revealed that amino acid substitutions at positions 83 and 87 of ciprofloxacin-resistant strains isolated in Bangladesh were similar to those of the strains isolated in Nepal, but different (at position 87) from ciprofloxacin-resistant strains isolated in India.
CONCLUSIONS: PFGE and mutation analysis of gyrA showed differences between the current ciprofloxacin-resistant S. dysenteriae 1 strains isolated in south Asia and those associated with epidemics in 1978, 1984 and 1994.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15347639     DOI: 10.1093/jac/dkh425

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  16 in total

1.  Alteration in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in Quinolone-resistant Shigella dysenteriae serotype 1 clinical isolates from Kolkata, India.

Authors:  Shanta Dutta; Yoshiaki Kawamura; Takayuki Ezaki; Gopinath Balakrish Nair; Ken-Ichiro Iida; Shin-Ichi Yoshida
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

2.  Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India.

Authors:  Neelam Taneja
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

3.  The emerging strains of Shigella dysenteriae type 2 in Bangladesh are clonal.

Authors:  K A Talukder; B K Khajanchi; M A Islam; D K Dutta; Z Islam; S I Khan; G B Nair; D A Sack
Journal:  Epidemiol Infect       Date:  2006-05-10       Impact factor: 2.451

4.  High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.

Authors:  Sumathi Sivapalasingam; Jennifer M Nelson; Kevin Joyce; Mike Hoekstra; Frederick J Angulo; Eric D Mintz
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Atypical class 1 integron coexists with class 1 and class 2 integrons in multi-drug resistant Shigella flexneri isolates from China.

Authors:  Jing Yuan Zhu; Guang Cai Duan; Hai Yan Yang; Qing Tang Fan; Yuan Lin Xi
Journal:  Curr Microbiol       Date:  2010-10-26       Impact factor: 2.188

6.  Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011.

Authors:  D Bhattacharya; H Bhattacharya; R Thamizhmani; D S Sayi; R Reesu; M Anwesh; C Kartick; A P Bharadwaj; M Singhania; A P Sugunan; S Roy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-29       Impact factor: 3.267

Review 7.  Antibiotic therapy for Shigella dysentery.

Authors:  Prince Rh Christopher; Kirubah V David; Sushil M John; Venkatesan Sankarapandian
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

8.  Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.

Authors:  Kaisar A Talukder; Bijay K Khajanchi; Mohammad A Islam; Zhahirul Islam; Dilip K Dutta; Mustafizur Rahman; Haruo Watanabe; Gopinath B Nair; David A Sack
Journal:  Curr Microbiol       Date:  2006-01-31       Impact factor: 2.188

9.  A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology.

Authors:  Lorenz von Seidlein; Deok Ryun Kim; Mohammad Ali; Hyejon Lee; Xuanyi Wang; Vu Dinh Thiem; Do Gia Canh; Wanpen Chaicumpa; Magdarina D Agtini; Anowar Hossain; Zulfiqar A Bhutta; Carl Mason; Ornthipa Sethabutr; Kaisar Talukder; G B Nair; Jacqueline L Deen; Karen Kotloff; John Clemens
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

10.  Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin.

Authors:  Mahbubur Rahman; Shereen Shoma; Harunur Rashid; Shams El Arifeen; A H Baqui; A K Siddique; G B Nair; D A Sack
Journal:  J Health Popul Nutr       Date:  2007-06       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.